Article

Mental Health Conditions Prevalent in Patients With Arthritis

Anxiety or depression affect a third of US adults with arthritis, CDC researchers report.

One-third of US adults aged 45 years and older with arthritis report having anxiety or depression, according to CDC researchers. Although there has been a stronger clinical focus on depression, anxiety is nearly twice as common in patients with arthritis, they noted. The findings are reported in Arthritis Care & Research, an American College of Rheumatology publication.

For the study, the researchers selected patients who were previous responders to the CDC's Arthritis Conditions and Health Effects Survey, a representative population of older US adults with arthritis symptoms, and identified 1793 participants with doctor-diagnosed arthritis or other rheumatologic conditions. They assessed anxiety and depression using the emotional well-being questions from the Arthritis Impact Measurement Scales.

Anxiety and depression were reported by 31% and 18% of the patients, respectively. One-third of the patients reported having at least 1 of the conditions, and 84% of those who had depression also had anxiety. No specific profile of characteristics for those with either mental health condition was apparent. Only half of the patients with arthritis and anxiety or depression had sought mental health treatment in the previous year.

Anxiety often is under-recognized and undertreated and until recently was overlooked as a potential risk factor for depression, it was noted. The researchers recommended that given the high prevalence of anxiety and depression in patients with arthritis and the effective treatment options that are available, all patients with arthritis be screened for these mental health conditions.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.